1)WHO:Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and mineral nutrition information system. World Health Organization, Geneva, 2011
2)Guralnik JM, et al:Prevalence of anemia in persons 65 years and older in the United States;Evidence for a high rate of unexplained anemia. Blood 104:2263-2268, 2004
3)Gurnari C, et al:How I manage acquired pure red cell aplasia in adults. Blood 137:2001-2009, 2021
4)Buttarello M:Laboratory diagnosis of anemia;Are the old and new red cell parameters useful in classification and treatment, how? Int J Lab Hematol 38(Suppl. 1):123-132, 2016
5)日本透析医学会:慢性腎臓病患者における腎性貧血治療のガイドライン.日透析医学会誌49:89-158, 2016
6)Ogawa C, et al:A hypoxia-inducible factor stabilizer improves hematopoiesis and iron metabolism early after administration to treat anemia in hemodialysis patients. Int J Mol Sci 21:7153, 2020
7)赤芽球癆の診断基準と診療の参照ガイド改訂版作成のためのワーキンググループ:赤芽球癆診療の参照ガイド 令和1年改訂版(第6版),2020 http://zoketsushogaihan.umin.jp/file/2020/03.pdf(2021年8月閲覧)
8)Hirokawa M, et al:Long-term outcome of patients with acquired chronic pure red cell aplasia(PRCA)following immunosuppressive therapy;A final report of the nationwide cohort study in 2004/2006 by the Japan PRCA collaborative study group. Br J Haematol 169:879-886, 2015
9)米村雄士,他:科学的根拠に基づいた赤血球製剤の使用ガイドライン(改訂第2版).日輸血細胞治療学誌64:688-699, 2018
10)輸血後鉄過剰症の診断基準と診療の参照ガイド改訂版作成のためのワーキンググループ:輸血後鉄過剰症診療の参照ガイド 令和1年改訂版(改訂第2版),2020 http://zoketsushogaihan.umin.jp/file/2020/05.pdf(2021年8月閲覧)